SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are expressing deep frustration over the token's prolonged underperformance and ongoing dilution, while simultaneously debating the potential impact of new app features and institutional investment on its long-term viability. Meanwhile, the community is actively buzzing about the native meme coin $MERY.X, which is gaining traction due to its strong correlation with $CRO.X and decentralized, 'rug-proof' narrative.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing intense community volatility following a significant share offering priced at $5, which has triggered widespread debate regarding management's dilution strategy and the company's long-term financial runway. While some investors are expressing frustration over stagnant growth and governance concerns, others are actively monitoring the stock for potential entry points or rebound opportunities as the market reacts to the new capital structure ahead of upcoming earnings.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt is facing significant downward pressure following its latest earnings report, which highlighted substantial revenue declines and net losses. Despite the bleak financial figures, the community remains divided, with some investors debating the potential of the company's strategic pivot toward AI-driven stablecoin infrastructure and cross-border payment rails.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing a surge in community engagement as investors track the CEO's involvement in high-level government roundtables on critical minerals and the company's role as a sole domestic supplier for defense applications. While community discourse remains heavily focused on potential supply chain catalysts, institutional activity, and the upcoming earnings report, sentiment is polarized between long-term holders eyeing strategic supply shortages and those concerned by recent volatility.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing heightened investor activity as the market digests conservative guidance and management's shift toward high-margin, branded ophthalmic products, with the community actively debating whether the company's long-term commercial platform can overcome recent revenue volatility. Shareholders are closely watching prescription volume data for VEVYE and upcoming J-code catalysts, viewing the current market price as a potential buying opportunity despite frustration over past communication gaps.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently trending as investors rotate into high-quality defensive healthcare stocks amid market volatility, while the community remains focused on the company's aggressive oncology pipeline expansion and potential for strategic acquisitions. Investors are actively discussing the company's ongoing litigation risks alongside its long-term growth prospects as a potential sector leader in cancer treatment.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging following a blockbuster quarterly report that saw revenue and gross margins significantly beat analyst expectations, signaling a major inflection point in its commercial growth. Investors are currently hyper-focused on the company's expanding treatment network and the upcoming, highly anticipated data for its lung cancer (NSCLC) program, which many in the community believe could trigger a massive valuation re-rating.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to strong quarterly results that surpassed revenue estimates and triggered an upward revision of full-year guidance. While the community is actively debating the stock's volatility and its long-term viability against competitors like Archer, many are focused on the company's progress toward FAA certification and the build-out of U.S. vertiport infrastructure.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is surging following a strong quarterly earnings report that significantly exceeded revenue and EPS expectations, signaling a major inflection point in data center optical demand. The community is actively discussing the stock's massive post-earnings rally, debating whether this marks a sustainable recovery in the AI optical infrastructure cycle or a volatile short squeeze.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is experiencing significant volatility and trading volume as investors react to mixed economic signals, including elevated inflation data and ongoing central bank gold accumulation. The community remains divided, with many debating whether the current pullback represents a strategic bottoming phase or a deeper correction driven by interest rate uncertainties and broader market instability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kratos Defense & Security Solutions is trending as investors focus on its strong backlog and position in key defense themes like hypersonics and autonomous drones, following a series of recent contract wins and bullish analyst upgrades. The community is actively debating the company's valuation against its long-term growth potential in an era of heightened global defense spending.

Ondas Bags Over $50M U.S. Army Order, Expands Defense Footprint

ONDS has secured a more than $50 million U.S. Army LUS order under Mistral's $982 million IDIQ contract, extending production visibility and its defense footprint.

KTOS Q2 Earnings Call Highlights Hypersonics and Engine Ramp-Up

Kratos ramps up hypersonics, jet engines and unmanned systems as new capacity, program funding and bookings support stronger second-half growth.

Ondas Stock Gains 21% in a Month: Is There More Upside Ahead?

ONDS stock surges 20.6% in a month as acquisitions and rising orders lift its outlook, but profitability issues and execution risks temper the upside case.

Fortinet  and Ecopetrol  have been highlighted as Zacks Bull and Bear of the Day

KTOS Stock Hits Two-Month High As Clear Growth Prospects Spur Piper Sandler Ratings Upgrade 

Equity

Investment firm Piper Sandler upgraded Kratos Defense & Security Solutions to Overweight with a $75 price target.

Can BigBear.ai Lead the Multi-Drone Mission AI Solutions Market?

BBAI's ConductorOS lets one operator manage multi-vendor drone fleets, targeting demand for autonomous defense mission systems.


Kratos Defense Q2 Earnings and Revenues Outpace Estimates

KTOS delivers sharp Q2 earnings and revenue growth as government solutions, organic gains and strong bookings support performance.

Why Kratos Defense Stock Is Surging Wednesday Following Q2 Double Beat and Guidance Raise

Kratos Defense & Security Solutions is surging Wednesday as traders digest a double beat and raised guidance from Tuesday's quarterly update.read more...

KTOS Stock Jumps Overnight On 30% Q2 Revenue Growth: CEO Sees ‘Hypersonic Arms Race’ Ahead 

CEO Eric DeMarco emphasized hypersonics, space and unmanned systems as key long-term growth drivers amid increasing U.S. defense spending. 


Kratos (KTOS) Surpasses Q2 Earnings and Revenue Estimates

Kratos (KTOS) delivered earnings and revenue surprises of +61.54% and +11.44%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Extremely Bullish Sentiment

$AVAV

$KTOS

$ONDS

$UMAC

Which of these drone stocks are you most bullish on for the next 5 years?

Current Price	$60.77
Prev Close	$57.41
Open	$57.97
Dividend Yield	0.00%
50-Day Moving Average	$52.67
Beta	1.35
Avg. Volume	3.84M
PE Ratio	349.45

52-Week High	$134.00
52-Week Low	$43.09
Market Capitalization	$10.78B
EPS (Annual)	$0.1332
Price to Book	3.33
Revenue Per Employee	$313,209.30

Feed

News

Sentiment

Earnings

Fundamentals

Info